板塊異動 | 醫療器械板塊反彈,春立醫療、微創醫療漲超8%
uSMART盈立智投12月3日消息,週四港股,醫療器械板塊出現反彈行情,截至14:52分,春立醫療、微創醫療漲超8%,沛嘉醫療-B漲超5%,愛康醫療漲超3%。
上半年牛氣沖天
集採成行情拐點
醫療器械板塊曾是牛股集中營,上半年漲勢牛氣沖天,7月中旬則成爲牛熊拐點,主因是醫療器械集採政策影響。
今年上半年,春立醫療一度累計漲超240%,愛康醫療一度累計漲超200%,現在幾乎回吐了今年全部漲幅;
微創醫療一度累計漲超350%,經歷一輪估值殺跌,目前修復部分大部分失地,年初至今累計漲幅仍有312%;
啓明醫療-B一度累計漲超150%,現年初至今累計漲幅仍有99%;
今年5月份上市的沛嘉醫療-B,也一度回吐上市以來的全部漲幅,並向下不斷探底,現出現小幅反彈行情。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.